CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,688 | -14.6% | 78,981 | +43.8% | 0.00% | – |
| Q2 2023 | $155,455 | -31.0% | 54,931 | +19.7% | 0.00% | – |
| Q1 2023 | $225,398 | -54.3% | 45,906 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $493,030 | +14.7% | 45,906 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $429,680 | +14.6% | 45,906 | +11.8% | 0.00% | 0.0% |
| Q2 2022 | $375,000 | -24.8% | 41,051 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $499,000 | +143.4% | 41,051 | +143.7% | 0.00% | – |
| Q4 2021 | $205,000 | -20.8% | 16,845 | +0.3% | 0.00% | -100.0% |
| Q3 2021 | $259,000 | +7.9% | 16,796 | 0.0% | 0.00% | – |
| Q2 2021 | $240,000 | -40.7% | 16,796 | -9.9% | 0.00% | -100.0% |
| Q1 2021 | $405,000 | +42.1% | 18,638 | -1.1% | 0.00% | 0.0% |
| Q4 2020 | $285,000 | +54.1% | 18,841 | +29.8% | 0.00% | – |
| Q3 2020 | $185,000 | -25.4% | 14,521 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $248,000 | -6.1% | 14,521 | -27.4% | 0.00% | 0.0% |
| Q1 2020 | $264,000 | -14.0% | 20,005 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $307,000 | +15.8% | 19,062 | +31.3% | 0.00% | 0.0% |
| Q3 2019 | $265,000 | -15.1% | 14,520 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $312,000 | +15.6% | 14,520 | +5.4% | 0.00% | 0.0% |
| Q1 2019 | $270,000 | +50.8% | 13,780 | 0.0% | 0.00% | – |
| Q4 2018 | $179,000 | -38.3% | 13,780 | +14.0% | 0.00% | -100.0% |
| Q3 2018 | $290,000 | +40.8% | 12,090 | +12.2% | 0.00% | – |
| Q2 2018 | $206,000 | +35.5% | 10,772 | -12.5% | 0.00% | – |
| Q1 2018 | $152,000 | +0.7% | 12,316 | 0.0% | 0.00% | – |
| Q4 2017 | $151,000 | -10.7% | 12,316 | 0.0% | 0.00% | – |
| Q3 2017 | $169,000 | -11.1% | 12,316 | 0.0% | 0.00% | – |
| Q2 2017 | $190,000 | -3.1% | 12,316 | +15.4% | 0.00% | – |
| Q1 2017 | $196,000 | +98.0% | 10,670 | 0.0% | 0.00% | – |
| Q4 2016 | $99,000 | +11.2% | 10,670 | 0.0% | 0.00% | – |
| Q3 2016 | $89,000 | +74.5% | 10,670 | 0.0% | 0.00% | – |
| Q2 2016 | $51,000 | – | 10,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $47,864,000 | 31.00% |
| Chescapmanager LLC | 1,484,303 | $25,382,000 | 4.27% |
| Cypress Capital Management LLC (WY) | 179,920 | $3,077,000 | 3.07% |
| DAFNA Capital Management LLC | 371,033 | $6,345,000 | 1.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $10,715,000 | 0.98% |
| Prosight Management, LP | 86,965 | $1,487,000 | 0.64% |
| ETF MANAGERS GROUP, LLC | 901,714 | $15,419,000 | 0.55% |
| Carmignac Gestion | 2,065,153 | $35,314,000 | 0.49% |
| Ikarian Capital, LLC | 273,524 | $4,677,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $39,330,000 | 0.32% |